54,70|C0854467|Myelosuppression|10065553
182,198|C0854467|myelosuppression|10065553
211,216|C1306577|death|10011906
235,245|C3714514|Infections|10021789
332,343|C0002792|Anaphylaxis|10002198
348,366|C0948715|Infusion Reactions|10051792
379,401|C0002792|anaphylactic reactions|10002198
534,554|C0041364|Tumor Lysis Syndrome|10045170
557,576|C0022660|Acute renal failure|10069339
581,586|C1306577|death|10011906
645,659|C0221743|Skin Reactions|10040914
710,713|C0038325|SJS|10042033
718,721|C0014518|TEN|10044223
728,733|C1306577|fatal|10011906
892,904|C1306459|Malignancies|10028997
906,919;934,942|C1514391|Pre-malignant diseases|10049673
924,942|C0442867|malignant diseases|10028997
980,993|C0015376|Extravasation|10015866
1097,1118|C0270009|Embryo-fetal toxicity|10026923
1121,1131|C0854268|Fetal harm|10016852
1335,1351|C0854467|myelosuppression|10065553
1441,1445|C1306577|died|10011906
1451,1493|C0854467|myelosuppression-related adverse reactions|10065553
1509,1527|C0877153|neutropenic sepsis|10049151
1529,1556|C0852879|diffuse alveolar hemorrhage|10037313
1570,1586|C0040034|thrombocytopenia|10043554
1592,1601|C0032285|pneumonia|10035664
1610,1633|C0029118|opportunistic infection|10030901
1624,1633;1635,1638|C0010823|infection CMV|10011831
2330,2339|C3714514|Infection|10021789
2351,2360|C0032285|pneumonia|10035664
2362,2368|C0243026|sepsis|10040047
2370,2382|C0036983|septic shock|10040070
2388,2393|C1306577|death|10011906
2503,2519|C0854467|myelosuppression|10065553
2577,2587|C3714514|infections|10021789
2775,2793|C0948715|Infusion reactions|10051792
2865,2870|C0015967|fever|10037660
2872,2878|C0085593|chills|10008531
2880,2888|C0033774|pruritus|10037087
2893,2897|C0015230|rash|10037844
2924,2936;2955,2964|C0002792|anaphylactic reactions|10002198
2941,2964|C0340865|anaphylactoid reactions|10002216
3734,3754|C0041364|Tumor lysis syndrome|10045170
3968,3987|C0022660|acute renal failure|10069339
3992,3997|C1306577|death|10011906
4254,4267|C1167791|skin toxicity|10059516
4406,4420|C0221743|Skin reactions|10040914
4526,4530|C0015230|rash|10037844
4532,4552|C0521465|toxic skin reactions|10057970
4557,4574|C0235819|bullous exanthema|10012441
4749,4775|C0014518|toxic epidermal necrolysis|10044223
4777,4780|C0014518|TEN|10044223
4869,4893|C0038325|Stevens-Johnson syndrome|10042033
4895,4898|C0038325|SJS|10042033
4904,4907|C0014518|TEN|10044223
4914,4919|C1306577|fatal|10011906
5115,5129|C0221743|skin reactions|10040914
5391,5404;5419,5427|C1514391|pre-malignant diseases|10049673
5409,5427|C0442867|malignant diseases|10028997
5506,5530|C3463824|myelodysplastic syndrome|10028533
5532,5560|C0027022|myeloproliferative disorders|10077465
5562,5584|C0023467|acute myeloid leukemia|10000880
5589,5608|C0007121|bronchial carcinoma|10006417
5719,5733|C0015376|extravasations|10015866
5806,5814|C0041834|erythema|10015150
5823,5831|C0038999|swelling|10042674
5837,5841|C0030193|pain|10033371
6100,6110|C0854268|fetal harm|10016852
6282,6290;6304,6317|C0795693|skeletal malformations|10062344
6295,6317|C3808677|visceral malformations|10061596
6323,6351|C0015934|decreased fetal body weights|10070531
